<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">71175</article-id><article-id pub-id-type="doi">10.26442/00403660.2021.04.200679</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Aortic stiffness and content of adipokines in the serum in persons of European and South Asian ethnic</article-title><trans-title-group xml:lang="ru"><trans-title>Жесткость аорты и содержание адипокинов в сыворотке крови у лиц европейской и южноазиатской этнической принадлежности</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9836-6339</contrib-id><name-alternatives><name xml:lang="en"><surname>Brodskaya</surname><given-names>Tatiana A.</given-names></name><name xml:lang="ru"><surname>Бродская</surname><given-names>Татьяна Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.м.н., доц. проф. Института терапии и инструментальной диагностики</p></bio><email>doc.ninaivanova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7507-1415</contrib-id><name-alternatives><name xml:lang="en"><surname>Repina</surname><given-names>Nina I.</given-names></name><name xml:lang="ru"><surname>Репина</surname><given-names>Нина Ивановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>ассистент Института терапии и инструментальной диагностики</p></bio><email>doc.ninaivanova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0117-0349</contrib-id><name-alternatives><name xml:lang="en"><surname>Nevzorova</surname><given-names>Vera A.</given-names></name><name xml:lang="ru"><surname>Невзорова</surname><given-names>Вера Афанасьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.м.н., проф., дир. Института терапии и инструментальной диагностики</p></bio><email>doc.ninaivanova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8701-7213</contrib-id><name-alternatives><name xml:lang="en"><surname>Plekhova</surname><given-names>Natalia G.</given-names></name><name xml:lang="ru"><surname>Плехова</surname><given-names>Наталья Геннадьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.б.н., зав. центральной научно-исследовательской лаб.</p></bio><email>doc.ninaivanova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9645-3471</contrib-id><name-alternatives><name xml:lang="en"><surname>Shumatov</surname><given-names>Valentin B.</given-names></name><name xml:lang="ru"><surname>Шуматов</surname><given-names>Валентин Борисович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д.м.н., проф., зав. каф. анестезиологии и реаниматологии.</p></bio><email>doc.ninaivanova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Pacific State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Тихоокеанский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2021</year></pub-date><volume>93</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>397</fpage><lpage>403</lpage><history><date date-type="received" iso-8601-date="2021-06-01"><day>01</day><month>06</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-06-01"><day>01</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/71175">https://ter-arkhiv.ru/0040-3660/article/view/71175</self-uri><abstract xml:lang="en"><p><bold>Aim. </bold>To evaluate the cardiovascular risk (CVR) based on arterial stiffness and content of adipokines in young-aged persons of different ethnicity (European and South Asian).</p> <p><bold>Materials and methods. </bold>290 persons of European (Slavic) and South Asian (Korean) ethnicity aged from 19 to 49 years with and without arterial hypertension (AH) were examined. Clinical, anthropometric, laboratory examinations were performed, levels of resistin and adiponectin of blood were assessed. Total CVR was assessed by SCORE scale, patients under the age of 40 years were assessed by relative risk scale. Aortic stiffness was examined by non-invasive arteriography.</p> <p><bold>Results. </bold>Patients of European ethnicity had higher blood pressure (BP), body mass index (BMI), waist circumference (WC), levels of resistin and adiponectin. Pulse wave velocity in the aorta (PWVA) did not differ significantly in ethnic groups. According to the SCORE scale in individuals of the European and South Asian races in general groups and groups with arterial hypertension a moderate absolute risk was determined, in individuals under 40 years of age a moderate relative risk was determined without a significant difference between the groups. However increased levels of PWVA (more than 10 m/s) were registered more often in Korean ethnicity (46.9% compared to Slavic ethnicity, 22.2%). Closer reliable correlations between the level of BP and BMI, WC, PWVA were revealed in Korean ethnicity. Ethnic differences in correlation of adipokines in blood and their dependence on anthropometric and hemodynamic characteristics were described.</p> <p><bold>Conclusion.</bold> The assessment of CVR according to traditional scales does not always accurately represent its real level. New information was obtained on the features of adipokine metabolism and its connections with early manifestations of vascular remodeling in young-aged depending on the race. Taking into account ethnic differences, we recommend in-depth diagnostics of CVR in South Asians. The data can be useful for the design of personalized programs for the diagnostics and assessment of CVR.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель.</bold> Оценить уровень кардиоваскулярного риска (КВР) с учетом показателей артериальной жесткости и уровня адипокинов у лиц молодого возраста разной этнической принадлежности (европейской и южноазиатской).</p> <p><bold>Материалы и методы.</bold> Обследованы 290 человек европейской (славянской) и южноазиатской (корейской) этнической принадлежности 19–49 лет с наличием и без артериальной гипертензии. Выполнены клинические, антропометрические, лабораторные исследования, оценен уровень резистина и адипонектина крови. Суммарный КВР определяли по шкале SCORE, до 40 лет – по шкале относительного риска. Жесткость аорты исследовали методом неинвазивной артериографии.</p> <p><bold>Результаты. </bold>У лиц европейской этнической принадлежности регистрировались более высокие показатели артериального давления, индекса массы тела, окружности талии, уровней резистина и адипонектина. Скорость распространения пульсовой волны в аорте (СПВА) достоверно не различалась в этнических группах. По шкале SCORE у лиц европейской и южноазиатской расы в общих группах и группах с артериальной гипертензией определен умеренный абсолютный риск, у лиц моложе 40 лет – умеренный относительный риск без достоверной разницы между группами. Однако у лиц корейской этнической принадлежности чаще (46,9% по сравнению со славянами – 22,2%) регистрировались повышенные значения СПВА (более 10 м/с). Выявлены более тесные достоверные корреляционные связи уровня артериального давления с индексом массы тела, окружностью талии, СПВА у лиц корейской этнической принадлежности. Описаны этнические различия соотношения адипокинов крови и их взаимосвязей с антропометрическими и гемодинамическими характеристиками.</p> <p><bold>Заключение. </bold>Оценка КВР по традиционным шкалам не всегда точно отражает его реальный уровень. Получены новые сведения об особенностях адипокинового обмена и его связях с ранними проявлениями сосудистого ремоделирования у лиц молодого возраста в зависимости от расы. С учетом этнических различий рекомендована углубленная диагностика КВР у южноазиатов. Данные могут быть полезны для разработки персонифицированных программ диагностики и оценки КВР.</p></trans-abstract><kwd-group xml:lang="en"><kwd>resistin</kwd><kwd>adiponectin</kwd><kwd>aortic stiffness</kwd><kwd>pulse wave velocity</kwd><kwd>ethnic differences</kwd><kwd>cardiovascular risk</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>резистин</kwd><kwd>адипонектин</kwd><kwd>жесткость аорты</kwd><kwd>скорость распространения пульсовой волны</kwd><kwd>этнические различия</kwd><kwd>кардиоваскулярный риск</kwd></kwd-group><funding-group><funding-statement xml:lang="en">This work was supported by the RFBR grant 19-29-01077 MK "Development of intelligent technology for assessing cardiovascular risk factors and building models for predicting cardiovascular events."</funding-statement><funding-statement xml:lang="ru">Работа выполнена при поддержке гранта РФФИ 19-29-01077 мк «Разработка интеллектуальной технологии оценки факторов кардиоваскулярного риска и построения моделей прогнозирования сердечно-сосудистых событий».</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Европейские рекомендации по профилактике сердечно-сосудистых заболеваний в клинической практике (пересмотр 2016). Рос. кардиол. журн. 2017;22(6):7-85 [2016 European guidelines on cardiovascular disease prevention in clinical practice. Ros. kardiol. zhurn. 2017;22(6):7-85 (In Russ.)]. doi: 10.15829/1560-4071-2017-6-7-85</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Tillin T, Hughes AD, Whincup P, et al. Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE – Southall And Brent REvisited). Heart. 2014;100(1):60-7. doi: 10.1136/heartjnl-2013-304474</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Бродская T.A., Невзорова В.А., Репина Н.И., Богданов Д.Ю. Вопросы оценки сердечно-сосудистого риска в зависимости от этнической принадлежности и поражения органов мишеней. Кардиоваскулярная терапия и профилактика. 2017;16(4):93-9 [Brodskaya TA, Nevzorova VA, Repina NI, Bogdanov DYu. An issue of cardiovascular risk assessment depending on ethnicity and target organ damage. Kardiovaskuljarnaja terapija i profilaktika. 2017;16(4):93-9 (In Russ.)]. doi: 10.15829/1728-8800-2017-4-93-99</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary. J Am Coll Cardiol. 2019;74(10):1376-414. doi: 10.1016/j.jacc.2019.03.009</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Бродская Т.А., Репина Н.И., Кондрашова Н.М., и др. Анализ механических свойств аорты в зависимости от статуса курения у лиц европейской и корейской этнической принадлежности. Тихоокеанский мед. журн. 2017;70(4):54-9 [Brodskaya TA, Repina NI, Kondrashova NM, et al. Analysis of mechanical properties of aorta depending on smoking status in persons of European and Korean ethnicity. Tihookeanskij med. zhurn. 2017;70(4):54-9 (In Russ.)]. doi: 10.17238/PmJ1609-1175.2017.4.54-59</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Чазова И.Е., Ощепкова Е.В., Жернакова Ю.В., и др. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Кардиологический вестн. 2015;10(1):3-30 [Chazova IE, Oshepkova EV, Zhernakova YuV, et al. Clinical guidelines Diagnostics and treatment of arterial hypertension. Kardiologicheskij vestn. 2015;10(1):3-30 (In Russ.)].</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-219. doi: 10.1093/eurheartj/eht151</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Беспалова И.Д., Рязанцева Н.В., Калюжин В.В., и др. Гендерные особенности взаимосвязи гормональной активности жировой ткани и провоспалительного статуса при гипертонической болезни с метаболическим синдромом. Бюл. сиб. медицины. 2014;13(5):12-9 [Bespalova ID, Ryazantseva NV, Kalyuzhin VV, et al. Gender features of interaction hormonal activity adipose tissue and proinflammatory status in hypertension with metabolic syndrome. Bjul. sib. mediciny. 2014;13(5):12-9 (In Russ.)]. doi: 10.20538/1682-0363-2014-5-12-19</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Korybalska K. Angiogenesis in Adipose Tissue: How can Moderate Caloric Restriction Affects Obesity-Related Endothelial Dysfunction? IntechOpen. 2017. Available at: https://www.intechopen.com/books/endothelial-dysfunction-old-concepts-and-new-challenges/angiogenesis-in-adipose-tissue-how-can-moderate-caloric-restriction-affects-obesity-related-endothel. Accessed: 09.10.2019. doi: 10.5772/intechopen.72624</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Вербовой А.Ф., Цанава И.А., Вербовая Н.И., Галкин Р.А. Резистин – маркер сердечно-сосудистых заболеваний. Ожирение и метаболизм. 2017;14(4):5-9 [Verbovoy AF, Tsanava IA, Verbovaya NI, Galkin RA. Resistin – a marker of cardiovascular diseases. Ozhirenie i metabolizm. 2017;14(4):5-9 (In Russ.)]. doi: 10.14341/omet201745-9</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Windham BG, Griswold ME, Farasat SM, et al. Influence of Leptin, Adiponectin, and Resistin on the Association Between Abdominal Adiposity and Arterial Stiffness. Am J Hypertens. 2010;23(5):501-7. doi: 10.1038/ajh.2010.8</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Shah AD, Kandula NR, Lin F, et al. Less Favorable Boby Composition and Adipokines in South Asians Compared to Other U.S. Ethnic Groups: Results from the MASALA and MESA Studies. Int J Obes. 2016;40(4):639-45. doi: 10.1038/ijo.2015.219</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Mente A, Razak F, Blankenberg S, et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care. 2010;33(7):1629-34. doi: 10.2337/dc09-1392</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Sulistyonningrum DC, Gasevic D, Lear SA, et al. Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc Diabetol. 2013;12:170. Available at: https://cardiab.biomedcentral.com/articles/10.1186/1475-2840-12-170. Accessed: 09.10.2019. doi: 10.1186/1475-2840-12-170</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Chen MC, Lee CJ, Yang CF, et al. Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients. Diabetol Metab Syndr. 2017;9:49. Available at: https://link.springer.com/article/10.1186/s13098-017-0247-8. Accessed: 09.10.2019. doi: 10.1186/s13098-017-0247-8</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Onat A, Aydın M, Can G, et al. High adiponectin levels fail to protect against the risk of hypertension and, in women, against coronary disease: involvement in autoimmunity? World J Diabetes. 2013;4(5):219-25. doi: 10.4239/wjd.v4.i5.219</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Yoon JH, Kim SK, Choi HJ, et al. Adiponectin provides additional information to conventional cardiovascular risk factors for assessing the risk of atherosclerosis in both genders. Plos One. 2013;8(10):e75535. doi: 10.1371/journal.pone.0075535</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Терещенко И.В., Каменских Я.А., Суслина А.А. Адипонектин в норме и патологии. Терапевтический архив. 2016;88(12):126-32 [Tereshchenko IV, Kamenskikh YaA, Suslina AA. Adiponectin in health and disease. Terapevticheskii Arkhiv (Ter. Arkh.). 2016;88(12):126-32 (In Russ.)]. doi: 10.17116/terarkh20168812126-132</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439-51. doi: 10.1210/er.2005-0005</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ohashi N, Ito C, Fujikawa R, et al. The impact of visceral adipose tissue and high-molecular weight adiponectin on cardio-ankle vascular index in asymptomatic Japanese subjects. Metabolism. 2009;58(7):1023-9. doi: 10.1016/j.metabol.2009.03.005</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Park S, Lakatta EG. Role of inflammation in the pathogenesis of arterial stiffness. Yonsei Med J. 2012;53(2):258-61. doi: 10.3349/ymj.2012.53.2.258</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Gupta M, Brister S. If South Asian ethnicity an independent cardiovascular risk factor? Can J Cardiol. 2006;22(3):193-7. doi: 10.1016/s0828-282x(06)70895-9</mixed-citation></ref></ref-list></back></article>
